Estrogen and BRCA1 deficiency synergistically induce breast cancer mutation-related DNA damage

Biochem Biophys Res Commun. 2022 Jul 12:613:140-145. doi: 10.1016/j.bbrc.2022.04.142. Epub 2022 May 2.

Abstract

Estrogen (E2) is crucial for the development of breast cancer caused by BRCA1 mutation, and can increase the DNA damage in BRCA1-deficient cells. However, the mechanisms through which BRCA1 deficiency and E2 synergistically induce DNA damage remains unclear. In this study, we analyzed the distribution of DNA damage in E2-treated BRCA1-deficient cells. We detected DNA lesions in the vicinity of genes that are transcriptionally activated by estrogen receptor-α (ER). Loss of BRCA1 altered chromatin binding by ER, which significantly affected the distribution of DNA damage. Moreover, these changes were associated with the established mutations in BRCA1-mutant breast cancer. Taken together, our findings reveal a new mechanism underlying the DNA damage in breast cancer cells that is synergistically induced by BRCA1 deficiency and E2.

Keywords: BRCA1; Breast cancer; DNA Damage; Estrogen; Estrogen receptor-α.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • BRCA1 Protein / genetics
  • BRCA1 Protein / metabolism
  • Breast / pathology
  • Breast Neoplasms* / metabolism
  • DNA Damage
  • Estrogen Receptor alpha / genetics
  • Estrogens / metabolism
  • Female
  • Humans
  • Mutation

Substances

  • BRCA1 Protein
  • BRCA1 protein, human
  • Estrogen Receptor alpha
  • Estrogens